In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://kaleewzi799736.blog5.net/85246531/delhi-high-court-confirms-government-approval-for-risdiplam-in-india